Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Clinical trial NCT06508775 · RECRUITING

Trial details

NCT number: NCT06508775
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Melanoma Stage III B-cell Non Hodgkin Lymphoma Pediatric ALL Childhood Non-Hodgkin Lymphoma Acute Lymphatic Leukemia Chronic Lymphatic Leukemia Melanoma Stage IV

Start date: 2024-05-05
Primary completion: 2040-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.